Telsey Advisory analyst Dana Telsey downgraded Bath & Body Works to Market Perform from Outperform with a price target of $17, down from $38. Bath & Body’s Q3 results missed expectations due to softer sales and weaker margins, with Q4 guidance signaling continued challenges amid macro pressure, the analyst tells investors in a research note. While the company remains a well-known brand with a loyal customer base, recovery is taking longer than anticipated, and topline and margin improvement is unlikely until the second half of 2026, limiting near-term visibility, Telsey says.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Nvidia resumed, Palo Alto downgraded: Wall Street’s top analyst calls
- Bath & Body Works price target lowered to $17 from $38 at Telsey Advisory
- Bath & Body Works price target lowered to $17 from $32 at UBS
- Cautious Hold Rating for Bath & Body Works Amid Strategic Shifts and Underperformance
- Bath & Body Works price target lowered to $26 from $32 at BofA